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[57] ABSTRACT 
A method for the solid-phase synthesis of peptides or 
proteins in high yield and high purity uses a solid sup 
port consisting of a functionalized polystyrene~grafted 
polymer substrate, the grafted polystyrene chains being 
substantially non-cross-linked and having a chain mo 
lecular weight, not including optional non-reactive sub 
stituents, of at least 200,000, preferably in the range of 
600,000—l,200,000. Particularly suitable polymer sub 
strates are substrates of a polyole?n such as polyethyl 
ene. The method is particularly well~suited to the com 
partmentalized synthesis of a multitude of peptides or 
proteins in a parallel and substantially simultaneous 
fashion. 
Preferred embodiments of a solid support for perform 
ing the synthesis are prepared from thin polyethylene 
sheet or ?lm which has been grafted with polystyrene 
chains in a radical-initiated process in which the poly 
ethylene sheet or ?lm is immersed in a solution of op 
tionally substituted styrene monomer in an alcohol such 
as methanol, the volume percentage of styrene in the 
solution preferably being about 30% v/v, and subjected 
to gamma irradiation. 
44 Claims, 5 Drawing Sheets 

US. Patent Dec. 13, 1994 Sheet 2 of 5 5,373,053 
QNQE mNdE 4N9“. $55: 2$5 : =m Ec3Qscm 
- _q- q
@558; 
I 
I 
I 
| 
t 
I 
I 
I 
I 
= I \- 
3.. 8 
\T 
l 1 
\ 
I l 
i i 
J. l 
I 
I 
F 
l 
l' 
US. Patent Dec. 13, 1994 Sheet 3 of 5 5,373,053 
mdE 
U.S. Patent Dec. 13, 1994 Sheet 4 0f 5 
mvd? E0.12m QWOmvdi466E mwhDEE mwhDZE‘ wwhDzzz m hbzzzw hDz  m FDZE‘ Om N0-9On NN.mON 0-1 cl1 q1 uq-1 dc‘
i 
i 
EzEQEw 
US. Patent Dec. 13, 1994 Sheet 5 of 5 5,373,053 
Azisnm 
M “1 LA 
o'lojzo'abo IO203OO lozosoo I0203O 
MINUTES - MINUTES MINUTES MINUTES 
FIG.4G FIG.4H FIG.4I FIG.4J 
215m" 
“KW L. L 1 l _l L A I 1 
0 IO 20 30 0 IO 20 300 IO 20 3O 
MlNUTES MINUTES MINUTES 
FIG.4K FIG.4L F|G.4M 
5,373,053 
1 
PEPTIDE SYNTHESIS METHOD AND SOLID 
SUPPORT FOR USE IN THE METHOD 
This application is a divisional application of applica 
tion Ser. No. 07/882,059, ?led May 12, 1992, and now 
U.S. Pat. No. 5,258,454 which application is a continua 
tion of application Ser. No. 07/398,846?led Aug. 25, 
1989 and now abandoned, which application is a con 
tinuation-in-part of application Ser. No. 07/239,525 
?led Sep. 1, 1988 and now abandoned. 
FIELD OF THE INVENTION 
The present invention concerns a method and a solid 
support for the solid-phase synthesis of peptides or pro 
teins in high yield ann in high purity. The method is 
well suited both to the synthesis of a single peptide or 
protein and to the parallel and substantially simulta 
neous synthesis of a multitude thereof. In particular, the 
invention concerns a method employing a polymer 
substrate grafted with polystyrene chains as the solid 
support, the polystyrene chains optionally further bear 
ing substituents which are not reactive under the condi 
tions prevailing in the synthesis, and having an esti 
mated molecular weight, not including optional substit 
uents, of at least 200,000. The invention employs con 
ventional chemical methodology and is readily adapted 
to both analytical (microgram) and preparative (milli 
gram or larger) scale synthesis. Furthermore, the inven 
tion is adaptable to both batchwise and continuous-?ow 
procedures operating manually, semi-automatically or 
fully automatically. 
BACKGROUND OF THE INVENTION 
Present day solid-phase methods for the synthesis of 
peptides or proteins are largely based on the original 
methodology developed by Merriiield, employing a 
functionalized cross-linked styrene/divinylbenzene co 
polymer, the cross-linked copolymer having been 
formed by the polymerization of styrene monomer to 
which has been added a few per cent (typically about 
2%) of divinylbenzene. This copolymer generally pro 
vided in the form of beads or particles, often with a 
dominant particle size of 20-80 pm. The functionaliza 
tion originally preferred by Merri?eld [see e.g. J. Am. 
Chem. Soc. 85, 2149 (1963)] was a functionalization of 
the aromatic rings of the copolymer with chloromethyl 
groups, introduced via reaction of the solid copolymer 
with SnCl4/chloromethyl methyl ether, although a 
number of other functionalities, including aminomethyl, 
a-aminobenzyl and a-amino-4-methylbenzyl, have sub 
sequently been employed. Regardless of its nature, the 
purpose of the functionality is normally to form an 
anchoring linkage between the copolymer solid support 
and the C-terminal of the ?rst amino acid which it is 
desired to couple to the solid support. More recent 
re?nements of the Merri?eld methodology have in 
cluded the further introduction, between a functionality 
(e.g. one of the above-mentioned functionalities) on the 
polystyrene chains and the C-terminal of the ?rst amino 
acid which is to be coupled, of a bifunctional “spacer" 
or “handle” group whose reactivity is tailored inter alia 
to meet desired requirements with respect both to the 
coupling of the ?rst amino acid to the solid support 
and/or to the ease with which the completed, synthe 
sized peptide or protein chain is cleaved from the solid 
support. Examples of such spacer groups include the 
phenylacetamidomethyl (Pam) and the p-alkoxybenzyl 
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ester systems. A recent review dealing with the devel 
opment of solid-phase peptide synthesis methodology 
since its introduction by Merri?eld is given by Barany 
et al. [Int J. Peptide Protein Res. 30, 705-739 (1987)]. 
Recent advances in biotechnology, particularly in the 
area of recombinant DNA, have produced a unique 
situation: the availability and rapid accumulation of 
many new protein sequences with unde?ned or un 
known function and/or unknown biological activity. 
Detailed structural analysis by site-directed mutagenesis 
or similar molecular engineering has provided a useful 
approach concerning the roles of amino acid residues in 
active sites of proteins. ' 
However, speci?c information concerning biologi 
cally active functional subunits containing ca. 5-4-0 
amino acid residues is preferably obtained through 
chemical synthesis. Current solid-phase technology is 
quite suf?cient to yield such peptides reliably and in 
high purity, but the conventional method of solid-phase 
peptide synthesis via a “linear” mode of approach pro 
duces only one peptide per synthesis. 
A method employing a “simultaneous” or “parallel” 
mode of approach to the synthesis of peptides is thus 
desirable, thereby facilitating the production of a large 
number of peptides which can, for example, be used to 
de?ne and map the functional entities of proteins. 
A basic feature of the solid-phase technique of pep 
tide synthesis is that in each elongation of the peptide 
chain with a further amino acid, all treatment steps are 
repetitive of the previous cycle with the possible excep 
tion of the amino acid coupling step itself, in which a 
further amino acid that may or may not be identical 
with that coupled in the preceding cycle is coupled to 
the peptide chain. Thus, a parallel, substantially simulta 
neous synthesis of more than one peptide can be 
achieved by performing in parallel the repetitive steps, 
such as deprotection, neutralization, and washing, 
which are common to the parallel syntheses. The major 
technical difficulty is the attainment of compartmental 
ization of each amino acid coupling step so that cross 
contamination will not occur. 
Two different methods have recently been proposed 
for the substantially simultaneous synthesis of a number 
of peptides: 
The ?rst of these methods [Geysen et al., Proc. Natl. 
Acad. Sci. USA. 81, 3998-4002 (1984) and 82, 178-82 
(1985)] was devised for rapid screening of peptide epi 
topes via ELISA (Enzyme Linked Immunosorbent 
Assay) in 96-microtiter wells. It utilizes acrylic acid 
grafted polyethylene rod-and-96-microtiter wells to 
immobilize growing peptide chains and to perform the 
compartmentalized synthesis. However, while highly 
effective, the method is not applicable on a preparative 
scale, i.e. to the ,preparation of milligram quantities. 
The second method [I-Ioughten, Proc. Natl. Acad. Sci. 
USA. 82, 5131-35 (1985)] utilizes a “tea bag” containing 
the traditionally used polymer beads to compartmental 
ize the synthesis, portions of peptidylresin beads being 
kept apart in sealed bags of ?ne-mesh polypropylene 
net. The latter method is relevant to the preparation of 
milligram quantities. 
The obvious advantages of a method permitting the 
parallel and substantially simultaneous synthesis of a 
multitude of peptides are the attendant saving in time 
and the redundancy of the repetitive labour involved in 
accomplishing the synthesis of each peptide individu 
ally. 
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BRIEF DISCLOSURE OF THE INVENTION 
The present invention comprises all the favorable 
aspects of both of the above-mentioned methods and, in 
addition, offers the advantages, already mentioned, of 
providing the desired peptide(s) or pr0tein(s) in high 
yield and high purity, and being equally well adaptable 
to both analytical and preparative scale syntheses. The 
invention will greatly bene?t studies in structure 
activity relationships, investigations such as mapping of 
antigenic epitopes, determination of details of hormone 
receptor interactions and screening for pharmacologi 
cally active peptidyl drugs, as well as being of great 
value in studies concerning the molecular organization 
of functional subunits of proteins in general. 
The invention is based on the provision and use of a 
solid support comprising a polymer substrate to which 
are grafted long and substantially non-cross-linked pol 
ystyrene chains which, under these conditions and pre 
sumably owing to the easy steric access thereto, func 
tion as particularly ef?cient solid-phase carriers for the 
peptides to be synthesized. 
The invention makes use of the insolubility of non 
cross-linked polyole?ns, e.g. polyethylene, in all or 
ganic solvents an ambient temperature. As the grafted 
polymer is still a thermoplastic material and soluble at 
elevated temperatures, reshaping is also possible. 
BRIEF DESCRIPTION OF THE FIGURES 
FIG. 1. Protection scheme for the solid-phase assem 
bly of [Asp76]hPTH fragment (70-84) on 443 wt % 
polystyrene-grafted polyethylene. 
FIGS. 2(A) through 2(C) Analytical HPLC chro 
matograms of (A) crude H-Lys-Ala-Lys-Ser-Gln-OH, 
(B) crude H-Val-Asp-Val-Leu-Thr-Lys-Ala-Lys-Ser 
Gln-OH, and (C) crude H-Ala-Asp-Lys-Ala-Asp-Val 
Asp-Val-Leu-Thr-Lys-Ala-Lys-Set-Gln-OH on 
uBONDAPAKT'M C13 (300x 3.9 mm, 10 um). Buffer 
A: PhD/0.095% CF3COOH; buffer B: 90% acetoni 
trile/ 10% HzO/0.072% CF3COOH; ?ow rate 1.3 
ml/min. 
FIG. 3. The amino acid sequences of melittin-(7-2l) 
and melittin-(7-2l) analogs. 
FIGS. 4-1 through 4-13 Analytical HPLC chro 
matograms of crude melittin-(7-2l) and analogs after 
low/high HF-cleavage (before lyophilization). Chro 
matogram l is that for crude melittin-(7-2l), i.e. peptide 
1, chromatogram 2 is that for crude peptide 2, etc. 
through crude peptide 13. Buffer A: 5% CH3CN/95% 
H20/0.0445% TFA; buffer B: 60% CH3CN/40% 
H2O/0.0390% TFA; linear gradient: 5-95% of B in 30 
min.; ?ow rate 1.5 ml/min.; column: Vydac C18 
(0.46X 25 cm). 
DETAILED DESCRIPTION OF THE 
INVENTION 
In one aspect of the present invention a method for 
the synthesis of a peptide or a protein is provided, the 
method comprising the steps of: 
A) providing a polymer substrate grafted with polysty 
rene chains, said polystyrene chains optionally fur 
ther bearing substituents which are not reactive 
under the conditions prevailing in the synthesis, the 
estimated molecular weight of substantially all of the 
polystyrene chains grafted to the polymer, not in 
cluding optional substituents, being at least 200,000, 
at least part of the polystyrene chains of the polysty 
rene-grafted polymer substrate being functionalized 
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with a chemical functionality facilitating the forma 
tion of an anchoring linkage between the polystyrene 
moiety and an at least N-protected and optionally 
carboxyl terminal derivatized amino acid, 
B) coupling an N-protected and optionally carboxyl 
terminal derivatized amino acid to the functionalized 
polystyrene moiety, said functionality and said N 
protected and optionally carboxyl terminal deriva 
tized amino acid being adapted to each other such 
that the anchoring linkage formed can subsequently 
be cleaved substantially without degradation of the 
peptide or protein chain which is to be synthesized, 
C) removing the N-protecting group from an N 
protected amino or substituted amino group of the 
coupled and N-protected amino acid, such that reac 
tion of the amino or substituted amino group of the 
coupled amino acid with a carboxyl group or an 
activated carboxyl group of a further amino acid is 
facilitated, 
D) reacting said amino or substituted amino group of 
the last 
coupled amino acid with a carboxyl group or an 
activated carboxyl group of a further N-protected 
amino acid so as to form peptide bond between the two 
amino acid moieties. 
E) optionally removing the N-protecting group from an 
N-protected amino or substituted amino group of the 
last-coupled N-protected amino acid, such that reac 
tion of the amino or substituted amino group of the 
latter amino acid with a carboxyl group or activated 
carboxyl group of a further N-protected amino acid is 
facilitated, 
F) in those cases where step E) has been performed, 
repeating steps D) and E) a desired number of times, 
G) optionally removing some or all protecting groups 
possibly remaining on the amino acid moieties of the 
synthesized peptide or protein chain, 
H) optionally cleaving the linkage anchoring the syn 
thesized peptide or protein chain to the functional 
ized polystyrene moiety, and 
I) optionally removing any further undesired group 
from the synthesized peptide or protein chain. 
The term polymer substrate as used in the present 
context denotes any suitable polymer which may be 
grafted as described and which in itself is substantially 
insoluble in and inert towards the reaction media used in 
the synthsis. Suitable polymers may be selected, for 
example, from polyamides, such as nylon, polyimides, 
poly(paraxylylenes), poly(halo?uoroalkenes), such as 
poly(tetra?uoroethylene) or poly(chlorotri?uoroethy 
lene), phenol-formaldehyde polymers and polyole?ns, 
such as polypropylene and polyethylene. The polymer 
substrate may be fashioned in any suitable form, for 
example a sheet, ?lm, bead, pellet, disc, ring, tube, rod 
or net. In preferred embodiments of methods for pep 
tide or protein synthesis according to the present inven 
tion, the polymer substrate is low-density polyethylene 
in the form of a sheet or ?lm, although experiments 
indicate (vide infra) that high-density polyethylene is 
also suitable. 
The polystyrene chains grafted to the polymer sub 
strate may be chains of polystyrene itself or of polysty 
rene which has been substituted to some extent with 
substituents which are not capable of reaction under the 
conditions prevailing in the synthesis. Such substituents 
may suitably be, for example, alkyl substituents, such as 
methyl, ethyl, propyl or butyl, alkoxy substituents, such 
as methoxy, ethexy, propoxy and butoxy, or aryloxy 
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substituents, such as phenoxy. The substitution will 
preferably take the form of substitution in the aromatic 
rings by one or more substituents, e.g. one or more of 
the above-mentioned substituents, although substitution 
at non-aromatic carbon atoms of vinyl group origin may 
also be envisaged. In preferred embodiments of meth 
ods for peptide or protein synthesis according to the 
present invention, the polymer substrate in these cases 
being polyethylene, the grafted polystyrene chains are 
chains of non-substituted polystyrene. 
It is believed to be particularly advantageous that the 
polystyrene chains grafted to the polymer substrate are 
of a molecular weight, not including optional substitu 
ents present on the polystyrene chains, of at least 
200,000. In a further aspect of the present invention, 
polystyrene chains ful?lling this condition may suitably 
be formed by a substantially radical-initiated reaction 
between the polymer substrate and optionally substi 
tuted styrene monomer present in a solution of the mon 
omer in an organic solvent. Experiments have shown 
(vide infra) that when a polyethylene sheet or ?lm is 
grafted with polystyrene chains under conditions where 
the polyethylene sheet or ?lm is immersed in solutions, 
of varying concentration, of styrene monomer in a sol 
vent such as methanol, the radical-initiated reaction 
being achieved by 'y-radiation, not only does a grafting 
reaction occur, but non-grafted (i.e. free) polystyrene 
chains are formed. While there at present is no obvious, 
straightforward way of determining accurately the mo 
lecular weight of the grafted polystyrene chains them 
selves, the molecular weight of the non-grafted polysty 
rene chains formed may readily be determined by, e. g., 
so-called “size-exclusion chromatography”. It has been 
found that when pure styrene monomer is used, i.e. no 
methanol is present, the molecular weight of the non 
grafted polystyrene chains (denoted hereafter as “ho 
mopolymer”) occluded in the sheet (and extracted from 
the sheet with dichloromethane) which are formed 
under a certain set of 'y-radiation conditions is predomi 
nantly about 180,000, and that the predominant molecu 
lar weight of the homopolymer increases with increas 
ing methanol content of the styrene monomer/me 
thanol solution; for example, in 70:30 (v/v) methanol/s 
tyrene the predominant molecular weight (Mpegk) is 
about 1,000,000. 
Results obtained with polystyrene-grafted polyethyl 
ene sheet grafted to various extents give strong indica 
tions that the molecular weight of the homopolymer 
occluded in the sheet and that of the grafted polysty 
rene chains correspond quite well, as will be explained 
at greater length in the following: 
Size-exclusion chromatography establishes a relation 
ship between species molecular weight and retention 
volume, the so-called “calibration curve”. The molecu 
lar weight of a given fraction of, for example, polysty 
rene homopolymer with a particular retention volume is 
determined by comparison with retention volumes for 
polystyrene standards of known molecular weight. 
However, since no polystyrene-grafted polyethylene 
standards of known chain molecular weight are avail 
able, the best that can be done is to compare with the 
retention volumes of polystyrene standards under the 
same solution conditions. 
The grafted sheet, the homopolymer and the polysty 
rene standards may be dissolved, e.g., in hot xylene, and 
in several such experiments the molecular weight of the 
most abundant fraction (Mpeak) of homopolymer was 
found to be ca. 1,000,000. The Mpeak value found for the 
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polystyrene-grafted polyethylene sheet on the basis of 
the above-mentioned comparison with retention vol 
umes of polystyrene standards was ca. 3,000,000 and 
upwards [it can be envisaged that a certain proportion 
of the individual polyethylene chains may be grafted 
with more than one polystyrene moiety, and the Mpwk 
value determined in the above manner for the polysty 
rene-grafted polyethylene may consequently be similar 
to or higher than that for the corresponding occluded 
polystyrene homopolymer]. 
Further evidence for the validity of the above 
described molecular weight estimation procedure can 
also be derived from the above-mentioned experiments 
as follows: 
The abundance, n,-, of a particular fraction, i, of mo 
lecular weight M,- is proportional to the height of the 
distribution curve at the retention volume correspond 
ing to M,-. The so-called “weight average molecular 
weight”, M», is then given by: 
while the so-called “number average molecular 
weight”, M”, is given by: 
Current theory concerning radical-initiated polymerisa 
tion predicts a Mw/Mn ratio (the “polydispersity”) of 
2.0. A value of ca. 2 was found for the homopolymer, 
and the value found for the polystyrene-grafted poly 
ethylene was also ca. 2, which may be taken as an indi 
cation that the polystyrene chains grafted to the poly 
ethylene substrate have grown in essentially the same 
manner as the homopolymer, thereby lending further 
credence to the molecular weight estimation procedure 
outlined above. The estimated molecular weights re 
ferred to in the present description and claims were 
estimated in the above-described manner. 
It is thus believed that the molecular weight of oc 
cluded homopolymer formed under a given set of con 
ditions (solvent, styrene concentration, temperature, 
'y-radiation intensity and duration of 'y-irradiation) 
closely re?ects the molecular weight of the grafted 
polystyrene chains formed under the same set of condi 
tions, the molecular weight determined for the homo 
polymer thus being taken as an estimate of the molecu 
lar weight of the grafted polystyrene chains. 
It is also believed that the density of grafting sites on 
the surface of a polymer substrate, i.e. the number of 
points of attachment of polystyrene chains per unit 
surface area, as well as the extent of cross-linking of the 
grafted polystyrene chains, is strongly influenced by the 
conditions under which grafting takes place, in particu 
lar by the nature of an organic solvent used in the graft 
ing process. Hydroxylic organic solvents, particularly 
alcohols such as methanol, are relatively hydrophilic 
and are therefore anticipated to be among the poorer 
solvents which may be chosen to dissolve a relatively 
hydrophobic substance such as styrene monomer. Thus, 
the degree of solvation of the monomer by such a sol~ 
vent is expected to be relatively low by comparison 
with the degree of solvation which would be expected 
with a more hydrophobic organic solvent, for example 
a halogenated aliphatic hydrocarbon such as dichloro 
methane (dichloromethane being a preferred reaction 
solvent in solid-phase peptide synthesis methodology, 
both in general and in the context of the present inven 
tion). It is believed that poor swelling or solvation of the 
5,373,053 
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grafted polystyrene chains during the grafting process 
in a solvent such as methanol maintains the mobility of 
the growing polystyrene chains at a low level thereby 
leading to retardation of the diffusion-controlled chain~ 
termination processes and thus facilitating the growth 
of particularly long polystyrene chains. 
An attractive feature of the high molecular weight of 
the grafted polystyrene chains in the context of the 
present invention is that when functionalized, they may 
be presumed to behave, with regard to their reactivity 
towards dissolved reagents, to a large extent as though 
they were non-grafted (i.e. free) functionalized polysty 
rene chains in homogeneous solution; the ease with 
which functionalized, grafted polystyrene chains 
formed in accordance with the present invention can 
react with dissolved reagents, including protected and 
optionally derivatized amino acids, may therefore be 
regarded as optimal. The apparent substantial absence 
of cross-linking between the polystyrene chains grafted 
to the polyole?n facilitates extensive swelling or solva 
tion of the chains by a chlorohydrocarbon solvent (in a 
preferred embodiment of the present invention dichlo 
romethane) such as generally preferred in solid-phase 
peptide syntheses. As mentioned previously, in conven 
tional solid-phase peptide synthesis procedures employ 
ing “Merri?eld-type” methodology, the solid support 
used is normally a functionalized cross-linked styrene/ 
divinylbenzene copolymer, the cross-linked copolymer 
having been formed by the polymerization of styrene 
monomer to which has been added a few per cent (typi 
cally ca. 2%) of divinylbenzene. This cross-linking re 
duces the degree of swelling or solvation of the func 
tionalized copolymer matrix relative to that prevailing 
for functionalized, grafted polystyrene chains formed in 
accordance with the present invention, and thereby 
correspondingly reduces the reactivity of the former 
matrix. 
According to the invention, it is preferred that the 
estimated molecular weight of substantially all of the 
polystyrene chains grafted to the polymer, not includ 
ing optional substituents, is in the range of 
300,000-1,600,000, in particular 400,000-l,400,000, 
preferably 600,000-l,200,000. The presently preferred 
estimated molecular weight of substantially all of the 
polystyrene chains is 700,000-1,000,000. It is believed 
that the higher estimated molecular weights of 400,000 
and above are particularly advantageous, but on the 
other hand, the grafting of polystyrene chains of the 
very highest estimated molecular weights of about 
1,000,000 and above appears to have a detrimental ef 
fect on the mechanical properties of the polymer sub 
strate, in particular when the substrate is, as is often 
preferred, in the form of a sheet or ?lm. 
The degree of polystyrene chain grafting of the poly 
mer substrate, that is, the weight percentage of polysty 
rene relative to the polymer substrate, depends, of 
course, on the length of the polystyrene chains, the 
grafting site density and the dimensions of the polymer 
substrate, and may vary within wide limits. Thus, in the 
case of, e.g., a sheet or ?lm of polymer substrate of 
thickness in the range of 25 to 100 pm, the degree of 
polystyrene chain grafting may be, e.g., from about 5 to 
about 800% by weight, such as from about 10% to 
about 700%. Both very low and very high degrees of 
polystyrene chain grafting, as well as intermediate de 
grees of grafting, are of value in the context of preferred 
embodiments of the present invention. 
25 
30 
50 
60 
65 
8 
Thus, for analytical purposes, where it is normally 
desired to be able to synthesize peptide sequences of 
proteins on a small scale, typically microgram scale, the 
provision,for example, of a polymer substrate with a 
relatively low degree of polystyrene chain grafting, 
such as, eg 5 to 200%, normally 10 to 60% (for a sheet 
or ?lm of polymer substrate of thickness in the range of 
25 to 100 um), and preferably with a controlled, often 
low extent of functionalization ensures controlled limi 
tation of the amount(s) of peptide(s) formed. 
Polystyrene-grafted polyethylene sheet or ?lm pro 
duced as preferred within the context of the present 
invention is particularly advantageous with respect to 
analytical aspects of peptide chemistry or biochemistry 
in that its high degree of transparency to light, particu 
larly visible light, facilitates the use of spectrophotomet 
ric techniques, e.g. for the monitoring (for example by 
an ELISA technique) of antigen/antibody reactions 
which can be monitored by a subsequent colour reac 
tion and in which the antigen may be a particular pep 
tide sequence synthesized on and remaining anchored to 
the solid support. 
For preparative purposes, where the attainment of 
the highest possible yield of a peptide or protein is 
clearly desirable, it is advantageous to use the highest 
practicable degree of grafting. From an overall point of 
view, the practical upper limit of the degree of grafting 
for a sheet or ?lm of polymer substrate of thickness in 
the range of 25 to 100 pm (as employed according to 
preferred embodiments) will often be about SOD-600% 
by weight, although special applications may make it 
desirable to exceed this range, such as to a degree of 
grafting of about 700%. On the other hand, the lowest 
degrees of grafting practicable will normally not be 
below about 40% for such a thin sheet or ?lm. For most 
practical purposes, the degree of grafting of such a thin 
sheet or ?lm will be in the range of about l00—600% and 
will often be in the range of 200-600% and, for prepara 
tive purposes, often preferably ZOO-400% by weight, 
which seems to be a suitable range both from the point 
of view of the yield and ef?ciency of peptide syntheses 
performed using functionalized, grafted sheet and from 
the point of view of mechanical strength of the grafted 
sheet or ?lm. 
As will be apparent from the examples illustrating the 
invention, extraordinarily high yields of highly pure 
peptides are obtainable, for example, using preferred 
embodiments of methods according to the present in 
vention which employ functionalized polystyrene 
grafted polyethylene sheet or ?lm formed from a poly 
ethylene substrate in the form of a thin sheet or ?lm of 
thickness in the vicinity of 50 um and with a degree of 
grafting in the vicinity of 400-500%. 
As mentioned above, in one aspect of the invention, 
the polystyrene-grafted polymer substrate is formed by 
a substantially radical-initiated reaction between the 
polymer substrate and optionally substituted styrene 
monomer present in a solution of said monomer in an 
organic solvent. As also mentioned above, it is advanta 
geous, from the point of view of obtaining long, sub 
stantially non-cross-linked polystyrene chains, to per 
form the grafting in a solvent in which the growing 
polystyrene chains are poorly swelled or solvated, such 
as a hydroxylic organic solvent, in particular an alcohol. 
Preferred alcohols for this purpose are C14 aliphatic 
alcohols. In practice, methanol has been found to be a 
most suitable solvent, but it is contemplated that also, 
e.g., ethanol, propyl and isopropyl alcohols, and n 
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butyl, iso-butyl, sec-butyl and tert-butyl alcohols will be 
applicablev 
The volume percentage (% v/v) of optionally substi 
tuted styrene in the solution used for the grafting, such 
as a solution in a solvent which swells or solvates the 
growing polystyrene chains poorly, e.g. a hydroxylic 
solvent as explained above, in particular an alcohol as 
explained above, such as, e.g, methanol, has a marked 
in?uence on the molecular weight of the grafted poly 
styrene chains formed, in that, at least up to a certain 
point, the chain-length-increasing effect of the solvent is 
greater, the greater the volume percentage of the sol 
vent in the solution. Thus, while the volume percentage 
of optionally substituted styrene in the solution may be 
within a very broad range, such as between 1 and 95%, 
this volume percentage will normally be in the range of 
10 to 90%, more usually 20 to 80%. A very interesting 
range for the volume percentage of the optionally sub 
stituted styrene in the solution is between 25 and 50%, 
and as will appear from the examples, a range of 25 to 
35%, in other words about 30% by volume, has been 
found in practice to give supports with excellent prop 
erties. An indication of the relation between the volume 
percentage of styrene in methanol during the grafting 
process and the resulting estimated polystyrene chain 
lengths appears from the below-mentioned experiments 
on the relationship between the volume percentage of 
the optionally substituted styrene in methanol and the 
molecular weight of the generated homopolymer at a 
constant 'y-radiation dose and dose-rate. 
The grafting process is very suitably performed by 
'y-irradiation in the absence of oxygen and at substan 
tially ambient temperature or slightly elevated tempera 
ture, the pressure being equal to the total vapour pres 
sure of the liquid components, optionally supplemented 
by a moderate pressure of an inert gas such as argon, the 
total pressure then amounting to about 1 atmosphere. A 
suitable way to remove oxygen from the reaction sys 
tem is to subject the system to repeated freeze-thaw 
cycles on a high vacuum apparatus. The 'y-irradiation is 
suitably performed at a dose rate in the range of from 
about 1 to about 100,000 Gy/hour, in particular about 
200-5000 Gy/hour, such as about 300-1000 Gy/hour. It 
is believed that the intensity of the irradiation is of con 
siderable importance to the obtainment of the desirable 
con?guration with long, substantially non-cross-linked 
polystyrene chains; if the intensity is too high, the free 
radical formation will be so high that the grafting will 
tend to involve a greater number of shorter chains and 
perhaps a higher degree of cross-linking, both of which 
are normally not desired. 
On the whole, the optimization of chain length, graft 
ing, and optical properties of the support (which is 
particularly important when the support is a sheet or 
?lm) is performed via the choice of polymer, optionally 
substituted styrene monomer, reaction mixture, radia 
tion dose-rate, and temperature during irradiation. 
While the above-described method involving 7' 
irradiation is the presently preferred method, it is con 
templated that polystyrene-grafted ?lms may suitably 
be prepared using a different strategy involving conven 
tional radical initiators, such as peroxides, for example 
hydrogen peroxide, benzoyl peroxide or diacetyl perox 
ide, or azo compounds as the radical-forming principles. 
Other radical-forming principles which may be em 
ployed are, e.g., ozone and UV-radiation; another par 
ticularly interesting radical-forming principle is an elec 
tron beam. The important thing is that the method used 
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for the radical generation be one which is suitable for 
relatively well-controlled radical-initiated growth of 
the polystyrene chains. It is believed that the conditions 
mentioned above concerning the importance of the 
properties of the solvent used also apply in connection 
with these free radical initiation principles. 
It is also contemplated that it may be possible to 
produce polystyrene/ polyethylene block copolymers 
useful for the present invention in a manner which does 
not make use of radical initiation. Thus, for example, it 
is possible using anionic polymerization to synthesize a 
block copolymer of butadiene and styrene, in which the 
chain length of the two blocks can be precisely con 
trolled. It is possible to hydrogenate this polymer in 
such a manner that the polybutadiene block is con 
verted into polyethylene. The polyethylene formed will 
have such a regular structure that it, in the solid state, 
will form high-density polyethylene. It is critical to this 
method that the polyethylene part of the copolymer 
should form a coherent ?lm. It is contemplated that this 
can be obtained in the following manner: the 
ethylene/styrene block copolymer is dissolved in a 
solvent in which the polystyrene part is soluble at room 
temperature and higher temperatures but in which the 
polyethylene part is only soluble when the solvent is 
hot. An example of such a solvent is xylene. The poly 
mer solution is placed in a mould and slowly cooled to 
below the temperature at which polyethylene precipi 
tates. When the polyethylene ?lm has been formed, the 
rest of the solvent is removed. 
It is further contemplated that the latter-outlined 
alternative method of preparation may be extended to 
the preparation of other polystyrene/polyole?n block 
copolymers, for example polystyrene/polypropylene 
block copolymer, by employing diene monomers other 
than butadiene, e.g. 2-methyl-l,3-pentadiene in the case 
of polystyrene/polypropylene block copolymer. 
While the polystyrene-grafted polymer substrate may 
be in any suitable form, such as explained above, very 
interesting embodiments of the invention are such in 
which it takes the form of a sheet or ?lm. The thickness 
of the polymer substrate itself, for example a polyethyl 
ene substrate, which is the starting material for such a 
sheet or ?lm, may vary within a wide range and will 
normally be from 10 to 10,000 pm, for most purposes 
preferably in the range 25 to 1000 pm, and typically in 
the range 25 to 100 pun such as 25 to 75 pm. The graft 
ing process leads, of course, to an increase in the thick 
ness. Thus, the thinner a sheet or film, the greater will 
the percentage increase in thickness be for a given set of 
grafting conditions. As an example, a thin grafted sheet 
or film may have a thickness in the range of 25 to 200 
pm. 
As the grafted polymer in the form of a sheet or film 
is a thermoplastic material and soluble at elevated tem 
peratures, reshaping after the grafting process is com 
plete is contemplated as a possibility. Thus, in the case 
of a polystyrene-grafted polyethylene sheet or ?lm, as 
preferred in the context of the present invention, it is 
possible to dissolve the sheet or film in a suitable solvent 
and allow the solution to cool and the solvent to evapo 
rate to obtain a new “casting” of the polymer support, 
e. g. as a thinner sheet or film, with the grafted polysty 
rene chains. The suitable solvent is one which, at a 
suitably high temperature, dissolves the polymer sup 
port with its grafted polystyrene chains (but with reten 
tion of the grafting) and which on cooling to a lower 
temperature is no longer capable of retaining the poly 
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mer substrate in solution, but still effectively swells or 
solvates the polystyrene chains. An example of such a 
solvent, useful, e.g., for polystyrene-grafted polyethyl 
ene, is a xylene or a mixture of xylenes. 
A sheet or ?lm has a number of advantages in the 
practical performance of peptide or protein synthesis. 
Thus, e.g., sheet or ?lm may easily be cut out in suitable 
sizes for arranging in the reaction vessels used, such as 
any type of known solid-phase peptide synthesis reac 
tion vessels, including ?asks, beakers, microbeakers, 
funnels, wells, columns or nets. 
The ?lm or sheet support makes it possible to devise 
new practical ways of handling the peptide synthesis. 
Thus, e.g., a number of sheet or ?lm pieces may be 
arranged on a common support and thus be kept to 
gether during the various stages of peptide synthesis, 
eg by being exposed together to the various reagents 
and washing solvents, or the pieces may be arranged in 
sets, each set being subjected to a particular combina 
tion of reaction media. 
This latter possibility facilitates ef?cient “compart 
mentalization” whereby two or more peptides can be 
prepared in a parallel and substantially simultaneous 
manner. 
Thus, in one aspect the invention provides a particu 
larly practical method for “compartmentalized” synthe 
sis of peptides and proteins, this aspect being based on 
the use of a polystyrene-grafted sheet or ?lm as the 
solid-phase peptide synthesis support. This aspect of the 
invention may be expressed as a method for the synthe 
sis of one or more peptides or proteins, which method, 
when two or more peptides or proteins are to be synthe 
sized, permits the parallel and substantially simulta 
neous synthesis of the desired number of peptides and 
proteins, the method comprising: 
A) providing a plurality of substantially identical poly 
mer substrates grafted with polystyrene chains, said 
polystyrene chains optionally further bearing substit 
uents which are not reactive under the conditions 
prevailing in the synthesis, at least part of the polysty 
rene chains of each polystyrene-grafted polymer sub 
strate being functionalized with a chemical function 
ality facilitating the formation of an anchoring link 
age between the polystyrene moieties and an at least 
N-protected and optionally carboxyl terminal deriva 
tized amino acid, 
B) optionally physically segregating the members of 
said plurality of polystyrene-grafted polymer sub 
strates into two or more sets each comprising one or 
more members of said plurality, coupling an N 
protected and optionally carboxyl terminal deriva 
tized amino acid to the functionalized polystyrene 
moieties of each member of said plurality or, where 
applicable, each member of each set, the N-protected 
and optionally carboxyl terminal derivatized amino 
acid employed being identical for all the members of 
the plurality or, where applicable, all the members of 
one set, and, where applicable, further being in accor 
dance with one of the following alternatives: 
(i) identical for all the sets, 
(ii) when the number of said sets is greater than two, 
identical for at least two of the sets, 
(iii) different for each set, 
said functionality and said N-protected and option 
ally carboxyl terminal derivatized amino acid being 
adapted to each other such that the anchoring linkage 
formed can subsequently be cleaved substantially 
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without degradation of the peptide or protein chain 
which is to be synthesized, 
C) treating each member of said plurality or, where 
applicable, each member of each said set so as to 
remove the N -protecting group from an N-protected 
amino or substituted amino group of the coupled and 
N-protected amino acid, such that reaction of the 
amino or substituted amino group of the coupled 
amino acid with a carboxyl group or an activated 
carboxyl group of a further N-protected amino acid is 
facilitated, 
D) reacting said amino or substituted amino group of 
the amino acid last coupled to the functionalized 
polystyrene moieties of each member of said plurality 
or, where applicable, of each member of each set with 
a carboxyl group or an activated carboxyl group of a 
further N-protected amino acid, so as to form a pep 
tide bond between said amino or substituted amino 
group and said carboxyl group or activated carboxyl 
group, said further N-protected amino acid being 
identical for all the members of the plurality or, 
where applicable, all the members of one set, and, 
where applicable, further being in accordance with 
one of the three alternatives mentioned above in con 
nection with step B), 
E) optionally treating each member of said plurality or, 
where applicable, each member of each said set so as 
to remove the N-protecting group from an N 
protected amino or substituted amino group of the 
last-coupled N-protected amino acid, such that reac 
tion of the amino or substituted amino group of the 
latter amino acid with a carboxyl group or activated 
carboxyl group of a further N-protected amino acid is 
facilitated, 
F) in those cases where step E) has been performed, 
repeating steps D) and E) a desired number of times, 
G) optionally treating each member of said plurality or, 
where applicable, each member of each said set so as 
to remove some or all protecting groups possibly 
remaining on the amino acid moieties of the synthe 
sized peptide or protein chain, 
H) optionally treating each member of said plurality or, 
where applicable, each member of each said set so as 
to cleave the linkage anchoring the synthesized pep 
tide or protein chain to the functionalized polysty 
rene moieties of each member of said plurality or, 
where applicable, of each member of each said set, 
and 
I) optionally removing any further undesired group 
from a synthesized peptide or protein chain. 
One practical way of handling the polymer support in 
the form of a sheet or film for compartmentalization 
purposes is to cut the sheet or ?lm into a desired number 
of pieces which are then marked indelibly, e. g. by 
means of graphite-based ink melted into the surface of 
some part of the sheet or ?lm. Another possibility is to 
have the various pieces present on one and the same 
large piece of sheet or film and then treat the different 
areas (which are suitably marked as described above) 
jointly or separately as the case may be. Evidently, one 
embodiment is to allow the pieces to remain on one and 
the same ?lm as long as the treatments to be performed 
are the same, and then divide the ?lm into sub-units 
when the steps to be performed are different. 
The chemical functionality facilitating the formation 
of an anchoring linkage between an at least N-protected 
and optionally derivatized amino acid and the function 
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alized polystyrene moiety is suitably a member of, or is 
derived from a member of the group comprising: 
chloro-, bromo- and iodo-substituted alkyl, 
amino-substituted alkyl, 
amino- and aryl-substituted alkyl, 
amino- and alkylaryl-substituted alkyl, 
hydroxy-substituted alkyl, 
the functionality, if derived from any of said group, 
being a functionality with a spacer group such that a 
synthesized peptide or protein chain will be clearable 
from the polystyrene moiety substantially without deg 
radation of said chain. 
According to suitable embodiments of the invention, 
chloro-substituted alkyl is chloromethyl, amino-sub 
stituted alkyl is aminomethyl, amino- and alkyl-sub 
stituted aryl is a-aminobenzyl (benzhydrylarnino), 
amino- and alkylaryl-substituted alkyl is selected from 
the group consisting of a-amino-2-, e-amin -3- and ot 
amino-4-methylbenzyl (the latter also being known as 
4-methylbenzhydrylamino), and hydroxy-substituted 
alkyl is hydroxymethyl. 
Concerning the initial functionalization of the polys 
tyrene-grafted polymer substrate, more than ?fty meth 
ods have been described in connection with traditional 
solid-phase peptide synthesis (see Barany and Merri?eld 
in The Peptides, Vol. 2, Academic Press, New York, 
1979, pp. 1-284, and Stewart and Young, Solid Phase 
Peptide Synthesis, 2nd Ed, Pierce Chemical Company, 
Illinois, 1984), of which reactions for the introduction 
of chloromethyl (via a chloromethyl methyl ether / 
SnCl4 reaction, aminomethyl (via a N-hydroxyme 
thylphthalimide reaction; see Mitchell et al., Tetrahe 
dron Lett, 3795, (1976)) and benzhydrylamino (Pietta 
and Marshall, J. Chem. Soc, 650 (1970)) groups are the 
most widely applied. Other reactive functionalities 
which have been initially introduced include 4-methyl 
benzhydrylamino and 4-methoxybenzhydrylamino. All 
of these established methods are in principle useful 
within the context of the present invention. Preferred 
embodiments of peptide or protein synthesis methods 
within the context of the present invention employ 
aminomethyl as the initial functionality, in that amino 
methyl is particularly advantageous with respect to the 
incorporation of “spacer” or “handle” groups owing to 
the reactivity of the amino group of the aminomethyl 
functionality with respect to the essentially quantitative 
formation of amide bonds to a carboxylic acid group at 
one end of the spacer-forming reagent. A vast number 
of relevant spacer- or handle-forming bifunctional rea 
gents have been described (see Barany et al., Int. J. 
Peptide Protein Res, 30, 705-739 (1987), especially rea 
gents which are reactive towards amino groups, such as 
the amino group in the aminomethyl function, including 
a 4-(haloalkyl)aryl-lower alkanoic acid such as 4 
(bromomethyl)phenylacetic acid, a Boc-aminoacyl-4 
(oxymethyl)aryl-lower alkanoic acid such as Boc 
aminoacyl-4-(oxymethyDphenylacetic acid, N-Boc-p 
acylbenzhydrylamine such as N-Boc-p-glutaroylbenz 
hydrylaniine, N-Boc-4'-lower alkyl-p-acylbenzhydryla 
mine such as N-Boc-4’-methyl-p-glutaroylbenzhydryla 
mine, N-Boc-4’-lower a1koxy-p-acylbenzhydrylamine 
such as N-Boc-4’-methoxy-p-glutaroylbenzhydrylamine 
and 4-hydroxymethylphenoxy-lower alkanoic acid such 
as 4-hydroxymethylphenoxyacetic acid. 
Certain functionalities,such as benzhydrylamino, 4 
methylbenzhydrylamino and 4-rnethoxybenzhy 
drylamino which may be incorporated for the purpose 
of cleavage of a synthesized peptide or protein chain 
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from the solid support such that the C-terminal of the 
peptide or protein chain is in amide form, require no 
introduction of a spacer group, and any such functional 
ity may advantageously be employed in the context of 
the present invention. 
An alternative strategy concerning the introduction 
of spacer or handle groups is the so-called "pre-formed 
handle” strategy (see Tarn et al., Synthesis, 955-57, 
(1979)), which offers complete control over coupling of 
the ?rst amino acid, and excludes the possibility of com 
plications arising from the presence of undesired func 
tional groups not related to the peptide or protein syn 
thesis. In this strategy, spacer or handle groups, in gen 
eral spacer or handle groups of the same types as de 
scribed above, are reacted with the ?rst amino acid 
which it is desired to anchor to the solid support, the 
amino acid being N-protected and optionally protected 
at other side-chains which are not relevant with respect 
to the building-up of the desired peptide or protein 
chain. Suitable N-protecting groups are Boc, normally 
in combination with benzyl groups for the protection of 
side chains, and Fmoc, normally in combination with 
t-butyl for the protection of any side chains (Boc=t 
butyloxycarbonyl; Fmoc=9-fluorenylmethyloxycarbo 
nyl), although a number of other possibilities exist 
which are well known in conventional solid-phase pep 
tide synthesis. 
Thus, in those cases in which a spacer or handle 
group is desirable, the ?rst amino acid to be coupled to 
the solid support can either be coupled to the free reac 
tive end of a spacer group which has been bound to the 
initially introduced functionality, for example arnino 
methyl, or can be reacted with the spacer-forming rea 
gent, which in turn is then reacted with the initially 
introduced functionality. 
Following completion of the coupling of the ?rst 
amino acid which is to be coupled, the next stage of the 
solid-phase synthesis is the systematic elaboration of the 
desired peptide or protein chain. This elaboration in 
volves repeated deprotection/coupling cycles. The 
temporary protecting group, such as a Bee or Fmoc 
group as described above, on the last-coupled amino 
acid is quantitatively removed by a suitable treatment, 
for example by acidolysis, such as with tri?uoroacetic 
acid, in the case of Boc, or by base treatment, such as 
with piperidine, in the case of Fmoc, so as to liberate the 
N-terminal amine function of the last-coupled amino 
acid. 
The next desired N-protected amino acid is then cou 
pled to the N-terminal of the last-coupled amino acid. 
This coupling of the C-terrninal of an amino acid with 
the N-terminal of the last-coupled amino acid can be 
achieved in several ways, for example by providing the 
incoming amino acid in a form with the carboxyl group 
activated by any one of several methods, including the 
initial formation of an active ester derivative, or the 
initial formation of an anhydride. Alternatively, the 
carboxyl group of the incoming amino acid may be 
reacted directly with the N-terminal of the last-coupled 
amino acid with the assistance of a condensation rea 
gent, for example dicyclohexylcarbodiimide or deriva 
tives thereof. 
Following the completed assembly of the desired 
peptide or protein chain, including protecting groups, 
the next seep will normally be deprotection of the 
amino acid moieties of the peptide or protein chain and 
cleavage of the synthesized peptide or protein from the 
solid support. These processes can take place substan 
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tially simultaneously, thereby providing the free pep 
tide in the desired form. Alternatively, in cases in which 
condensation of two separately synthesized peptide or 
protein chains is to be carried out, it is possible by 
choosing a suitable spacer group at the start of the syn 
thesis to cleave the desired peptide or protein chains 
from their respective solid supports, both peptide or 
protein chains still incorporating their side-chain pro 
tecting groups, and ?nally removing the side-chain 
protecting groups after, for example, coupling the two 
side-chain protected peptide or protein chains to form a 
longer peptide or protein chain. A third possibility, 
which is particularly relevant for example in the case of 
analytical aspects of peptide chemistry or biochemistry, 
is to remove the side-chain protecting groups from the 
synthesized peptide or protein chain without cleaving 
the anchoring linkage holding the chain to the solid 
support. 
It is envisaged that polystyrene-grafted polyethylene 
substrates analogous to those of the present invention, 
but comprising linker or spacer groups adapted to the 
particular chemistry in question, may be valuable in the 
synthesis of single or multiple biopolymer molecules 
other than peptides. One example would be the synthe 
sis of oligonucleotides, these being conceptually simple 
to synthesize since only four different reaction compart 
ments are normally required, one for each of the four 
nucleotide units involved (i.e. A, T, G and C for DNA 
fragments, or A, G, C and U for RNA fragments). Such 
syntheses could be carried out in a parallel and substan 
tially simultaneous fashion, in a manner analogous to 
that described within the context of the present inven 
tion. 
The following examples illustrate the invention, the 
abbreviations used being as follows: 
LIST OF ABBREVIATIONS 
Boc: tert-butyloxycarbonyl 
ClZ: 2-chlorobenzyloxycarbonyl 
DCC: N,N'-dicyclohexylcarbodiimide 
DCU: N,N'-dicyclohexylurea 
DIEA: N,N-diisopropylethylamine 
DMF: N,N-dimethylformamide 
FABMS: Fast atom bombardment mass spectrometry 
HOBt: l-hydroxybenzotriazole 
HPLC: high performance liquid chromatography 
Pam: phenylacetarniclomethyl 
PE: polyethylene 
PP: polypropylene 
SEC: size-exclusion chromatography 
SPPS: solid phase peptide synthesis 
TFA: tri?uoroacetic acid 
TFMSA: trifluoromethanesulfonic acid 
THF: tetrahydrofuran 
The abbreviations used for the various amino acids 
are in accordance with the recommendations of the 
IUPAC-IUB Commission of Biochemical Nomencla 
ture [1. Biol. Chem, 247, 977-983 (1972)], and refer in 
all cases to L-con?guration amino acids. 
EXAMPLE 1 
General procedure for preparation of 
polystyrene-grafted polyethylene sheets 
Styrene (99% Aldrich) was passed through basic 
alumina; in some cases it was further distilled vfrom 
sodium or from calcium hydride. 20 ml of a 30% (v/v) 
solution of purified styrene in methanol was placed in 
an ampoule together with a rectangular strip of low 
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density PE sheet which had been washed in n-hexane. 
The sheet used had a thickness of 54 pm. The solution 
was thoroughly degassed by repeated freeze-thaw cy 
cles on a high vacuum line and the ampoule was then 
sealed under vacuum. The ampoule and contents were 
then irradiated in a cobalt gamma-irradiation facility. 
The irradiation was carried out in two stages, the am 
poule being moved from one location in the irradiation 
source to another between the two stages to ensure as 
homogeneous a dose distribution as possible. The dose 
rate was approximately 400 Gy/hour. The highest dose 
rate used was 417 Gy/hour and the lowest 339 Gy/ 
hour. After irradiation the sheet was extracted in a 
Soxhlet apparatus with dichloromethane and dried. 
Speci?c data are listed in Table 1. It is noteworthy that 
although there is a clear correlation between the irradi 
ation dose and the extent of the grafting, there is much 
scatter in the data. This is partly due to the so-called 
“after effect”, the polymerization process continuing to 
some extent after the irradiation is stopped. As an exam 
ple of this effect the ampoule containing the sheet irra 
diated with a total dose of 3.4 kGy to yield a 450% 
grafted sheet was left outside the irradiation source for 
10 hours between the two stages of irradiation. Further 
more, the ampoule was ?rst opened 10 days after com 
pletion of irradiation. A similar procedure was used for 
the sheet irradiated with a total dose of 2.0 kGy to yield 
230% grafting. 
TABLE 1 
Grafting of PE sheets ill methanol/styrene (70% v/iQ 
Irradiation 
dose (kGy) Duration of 
Mass of PE (Irradiation Graft extraction with 
sheet (g) time in hours) %' CHgCl; (hours) 
0.2288 5.6 (14.0) 547 30 
0.290 4.0 (10.0) 443 96 
0.3322 3.4 (9.0) 450 330 
0.2742 3.0 (8.1) 220 240 
0.3866 2.9 (8.0) 285 170 
0.3400 2.7 (6.7) 23] 90 
0.2398 2.4 (6.0) 173 120 
0.3399 2.0 (6.0) 230 185 
0.3502 1.7 (4.8) 200 182 
0.3710 1.7 (5.0) 180 260 
0.3456 1.0 (3.0) 75 56 
0.3335 1.0 (3.0) 55 i14§ 
0.3831 0.98 (2.8) B0 119 
': Graft % = [(mass of ?nal sheet) - (mass of polyethylene)] >< [ID/(mass of 
polyethylene) 
§1 The top of the sheet was damaged during the closure of the ampoule. 
Sheets with graft % 46, 129 and 331, respectively, have 
also been prepared. 
EXAMPLE 2 
Procedure for grafting on non-woven felt made from 
fibers consisting of a polypropylene core and another 
layer of high-density polyethylene 
The non-woven PP/PE felt was washed with n-hex 
ane and irradiated in a closed ampoule containing a 
degassed 30% (v/v) solution of puri?ed styrene in 
methanol in a manner completely analogous to the gen 
eral procedure described in Example 1. The results are 
given in Table 2. 
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TABLE 2 
Grafting of PP/PE non-woven felt in methanol/styrene (70:30 v/v) 
Irradiation 
dose (kGy) Duration of 
Mass of PP/ (Irradiation Graft extraction with 
PE felt (g) time in hours) %' CHgClz (hours) 
0.2400 1.6 (4.5) 86 124 
0.2084 2.1 (6.0) 106 72 
': Graft % = {(mass of ?nal sheet) - (mass of polyethylene)] x lOO/(mass of 
polyethylene) 
EXAMPLE 3 
In?uence of methanol/styrene ratio on grafted 
polystyrene chain length 
The following results were obtained for irradiation of 
low—density polyethylene sheets in different me 
thanol/styrene mixtures (5 kGy dose, 400 Gy/hour 
dose rate, room temperature): 
Peak molecular 
% Methanol in weight of 
solvent (v/v) homopolymer 
0 180,000 
20 300.000 
40 500,000 
70 800,000 
It is seen that the molecular weight (determined by 
size-exclusion chromatography on cross-linked styre 
ne/divinylbenzene column material) of the homopoly 
mer fraction occluded amongst the grafted chains of the 
polystyrene-grafted polyethylene sheets and extracted 
from the sheets with dichloromethane increases as a 
function of the methanol/styrene ratio in the solution. 
At the same time the molecular weight distribution 
tends to become more narrow for high methanol/sty 
rene ratios. 
EXAMPLE 4 
Experiments on the estimation of the molecular weight 
of the grafted polystyrene chains 
The polystyrene homopolymer extracted from the 
sheets was characterized by SEC. The extracted poly 
styrene shows typically a molecular weight distribution 
with two bulges. This is due to the fact that polystyrene 
is formed both in the sheet and in the surrounding solu~ 
tion during irradiation. If a sheet is washed brie?y in 
diehloromethane before carrying out Soxhlet extrac 
tion, the amount of low molecular weight fraction is 
greatly reduced relative to that of the high molecular 
weight fraction. Molecular weight data for the high 
molecular weight fraction of the extracted homopoly 
mer are given in Table 3. Typical sample sizes were 
from 0.01 mg to 0.2 mg of polymer. For the homopoly 
mer from the sheets grafted to the extent of 173, 220, 
231 and 450 wt %, respectively, a 60 cm column of 
Toyo Soda TSK GMH6 was used for SEC at ambient 
temperature with THF as the eluent and a ?ow rate of 
0.5 ml/ min. For the homopolymer from the sheet 
grafted to the extent of 443 wt %, a 50 cm column of 
Shodex ASD-M was used for SEC at 50“ C. with xylene 
as the solvent and a ?ow rate of 0.5 ml/min. This set-up 
was also used for SEC of the grafted polymer formed, 
but now operating at 90° C. and with a flow rate of 
approximately 0.3 ml/min. The grafted sheets are solu 
ble in hot xylene. Molecular weight data for polysty 
rene-grafted polyethylene from the ?ve grafted sheets 
15 
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25 
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are given in Table 4. All molecular weight data given 
were calculated using a calibration curve based on poly 
styrene standards with molecular weights from 2800 
g/mol to 8,000,000 g/mol, the form of the calibration 
curve being ?tted by a third-order polynomial. The use 
of a ?rst-order (linear) calibration curve leads to similar 
results. It should be noted that whereas the molecular 
weights obtained for the styrene homopolymer are ab 
solute, the molecular weights obtained for the graft 
copolymer are not absolute. In the case of the Shodex 
A80-M column, extrapolation of the calibration curve 
was necessary in order to calculate the extremely high 
molecular weights observed. This extrapolation may 
lead to underestimation of the weight average molecu 
lar weight and consequently also of the polydispersity. 
The ungrafted polyethylene was characterized by high 
temperature SEC using 1,2,4-trichlorobenzene as the 
eluent. The following values were obtained: 
Mw=4>< 104 g/mol and M... n=5. The latter data 
were obtained using a calibration curve based on poly 
styrene standards. 
The data for the polystyrene homopolymers indicate 
that the molecular weight is insensitive to the total 
radiation dose, whereas for the polystyrene-grafted 
polyethylene the measured molecular weight is largely 
proportional to the dose. These observations indicate 
that the very long chain grafts are formed during the 
entire irradiation process and that essentially only the 
number of grafts is affected by the dose. 
TABLE 3 
Molecular weight data for the high molecular weight fraction of 
the polystyrene homopolymer extracted from the irradiated sheets 
Mw# 
Graft Irradiation (>< 1o~6 
% dose (kGy) mol/g) M w/M,,§ 
450 3.4 1.4 2.2 
443 4.0 2.6 3.7 
231 2.7 1.2 2.3 
220 3.0 1.2 2.2 
173 2.4 1. l 2.2 
#: M, = weight average molecular weight 
§: MJM, = weight average molecular weight divided by number average molecu~ 
lar weight 
TABLE 4 
Molecular weight data for the polystyrene-grafted polyethylene 
from the irradiated sheets. 
Mw# Mpeak' 
Graft Irradiation (x 10-6 x 10-6 
% dose (kGy) mol/ g) MWMR§ mol/g) 
450 3.4 1.0 1.6 7.2 
443 4.0 6.6 1.8 6.1 
231 2.7 2.9 2.2 3.5 
220 3.0 4.1 1.6 4.5 
113 2.4 4.1 1.6 3.1 
#: M‘. = weight average molecular weight 
§: MJM, : weight average molecular weight divided by number average molecu 
lar weight 
‘: M PM,‘ = molecular weight at the peak point in the chromatogram 
EXAMPLE 5 
Reshaping of a polystyrene-grafted polyethylene sheet 
A piece of 173% graft sheet (cf. Table 1) was dis 
solved in xylene at 100° C. and the solution poured into 
a te?on mold at 80° C. After slow evaporation of the 
xylene a very thin film was formed. Because of the 
extreme thinness of the film it was not possible to obtain 
anything but small pieces (1 to 2 mm square) of film. 
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However, these small pieces did not disintegrate when 
exposed to dichloromethane. This implies that a contin 
uous polyethylene phase is reformed. 
EXAMPLE 6 
Aminomethylation (functionalization) of 
polystyrene-grafted PE sheets 
Eight equally sized rectangilar strips (1.5 ><4.5 cm) of 
443% polystyrene-grafted polyethylene sheet (1.30 g 
total) were placed in a 60 ml SPPS reaction vessel on a 
manual SPPS shaker and washed with 40 ml of 
TFA/CH2C12(1:1 v/v) for 3 X 5 min. A solution of 0.35 
g (1.9 mmol) N-(hydroxymethyDphthalimide (97% pu 
rity; EGA-CHEMIE) in 40 ml of TFA/CHzClz (1:1 
v/v) was added to the washed sheets and the mixture 
was shaken for 10 min. 10 ml of TFMSA/T 
FA/CHzClg (10:45:45 v/v/v) was added slowly over a 
4-5 hour period and shaking was continued for another 
3 hours. The sheets were isolated by ?ltration and 
washed sequentially with the following: TFA/CH2Cl2 
(1:1 v/v) (120 ml), CHgClz (240 ml), methanol (160 ml), 
and ethanol (160 ml). They were then shaken in 40 ml of 
ethanol containing 10% of hydrazine (Fluka) for 12 
hours at 70° C. The sheets were filtered from the hot 
mixture and washed sequentially (with 20 min shaking 
for each wash) with the following: hot ethanol (3X40 
ml), hot DMF (3X40 ml), hot ethanol (3X40 ml), hot 
methanol (3X40 ml), and CHgClz (3 X40 ml). Finally, 
the sheets were treated with 40 ml of DIEA/CHgClg 
(1:9 v/v) for 2X 5 min, washed with 200 ml of CHzClz, 
and dried at room temperature. A total of 4 spectropho 
tometric ninhydrin colour tests indicated 1.00 mmol 
NHQ/ g sheet (0.99, 0.96, 1.02, and mmol/ g, respec 
tively), and elemental analysis indicated 1.07 mmol N/ g 
sheet. 
The following polystyrene-grafted polyethylene 
sheets have also been aminomethylated: 
331% grafted sheet: substitution = 0.21 mmol NHg/g sheet. 
547% ” 0.46 " 
129% " 0.50 " 
46% " 0.02 " 
285% " 0.6 " 
EXAMPLE 7 
Preparation of BocGln-4- (oxymethyD-Pam-sheet 
0.63 g arninomethyl-sheet (substitution= 1.0 mmol/g 
sheet; 443% graft) was pre-washed in 30 ml 
DMF/CHZCIZ (1:2 v/v) for 3X 3 min a 60 ml reaction 
vessel on a SPPS shaker. 0.98 g Boc-Gln-4-(oxyme 
thyl)phenylacetic acid (2.5 mmol, 4 equiv.) and 0.38 g 
HOBt (2.5 mmol. 4 equiv.) were dissolved in 20 ml 
DMF/CHZCIZ (1:1 v/v) and stirred in a screw-capped 
tube for 3 min at 0° C. 0.52 g DCC was dissolved in lid 
ml CHgClg and added to the mixture. After stirring for 
25 min at 0° C., DCU was ?ltered off and the filtrate 
was added to the pre-washed aminomethyl-sheet and 
shaken for 2 h. The sheets were ?ltered, washed with 
CH2C12, neutralized with DIEA/CHZCh (5:95 v/v), 
washed with CHZCIZ, and dried. The absence of posi 
tive ninhydrin tests indicated quantitative coupling, 
which was also con?rmed after removal of the Boo 
group by the following treatment: 30 ml TFA/CHgClz 
(1:1 v/v) for 1X2 min and 1X30 min, 30 ml CHgCl; for 
6 X 1 min, 30 ml DIEA/CHZCIZ (S :95 v/v) for 2 x 5 min, 
and 30 ml CHgClg for 4X 1 min. 2 ninhydrin tests then 
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indicated the extent of -—NH2 substitution to be 0.76 
mmol NHz/g sheet (0.74 and 0.77 mmol/g, respec 
tively), which is very close to the theoretical value of 
0.78 mmol NH? g sheet. 
EXAMPLE 8 
Peptide Synthesis: (a) Assembly of Protected Human 
[Asp76]Parathyroid Hormone Fragments 80-84, 75-84 
and 70-84 on 443 wt % Polystyrene-grafted 
Polyethylene Sheet 
BocGln-OCI-lg-Pam-sheet (0.80 g, 443% graft, 0.58 
mmol Gln) was placed in a 60 ml reaction vessel on a 
SPPS shaker. Protected hPTH 70-84, (see FIG. 1) was 
assembled using the following synthetic protocol: 
(1) CHzClz, 35 ml, 3X 1 min; 
(2) TFA/CHgClz (1:1 v/v), 35 ml, 3X 1 min; 
(3) TFA/CH2C12(1:1 v/v), 35 ml, 30 min; 
(4) CHzClz, 35 m1, 6X1 min; 
(5) DlEA/CHzCh (1:19 v/v), 35 ml, 3X2 min; 
(6) CHZCIZ, 35 ml, 6X1 min; 
(7) 3 to 10 mg samples were cut off for ninhydn'n analy 
sis; 
(8) protected amino acid was coupled as pre-forrned 
symmetric anhydride (3 equiv., 0.05M) in 35 ml 
DMF/CH2C12 (1:4 v/v), with shaking for 2 hours; 
(9) CHZCIZ, 35 ml, 4X2 min: 
(10) 3 to 10 mg samples were cut off and neutralized by 
repeating (5) and (6) before ninhydrin analysis. 
All couplings were single couplings. Monitoring of 
the synthesis by using the quantitative ninhydrin test 
[originally developed for peptide synthesis on beads; see 
e.g. Sarin et al., Anal. Biochem, 117, 147 (1981)] was 
successfully applied (Table 5), and with the exception 
(for unknown reasons) of the result for the second 
amino acid coupling (i.e. with formation of Boc 
Sers3(Bzl)Gln84-OCH2-Pam-sheet), indicated satisfac 
tory values for the coupling efficiency in each coupling 
step. 
TABLE 5 
Quantitative uinhydrin monintorlng“ of the solid-phase synthesis 
of protected human parathyroid hormone fragment (70-84) on 
443 wt % polystyrene-grafted polyethylene 
Couplingb Theo 
Remaining Esti- retical 
free amino mated‘ Measured substi 
Residue groups % oom- substitution tution 
coupled (pmol/g) pletion (mmol/g) (mmol/g) 
s4 BocGlnXd 0.0 100 0.10 i 0.02 on 
83 BocSer(Bzl) 38.0 94.0 0.35 i 0.04 0.69 
82 BocLys(2C1-Z) 1.6 99.7 0.54 i 0.03 0.57 
81 BocAla 0.6 99.9 0.52 i 0.03 0.55 
80 BocLys(2C1-Z) 1.2 99.7 0.53 i 0.02 0.47 
79 BocThr(Bzl) 0.0 100 0.44 i- 003 0.43 
78 BocLeu 0.4 99.9 0.39 i 0.01 0.41 
77 BocVal 0.0 100 0.39 i 0.03 0.40 
76 BocAsp(OBzl) 0.0 100 0.35 i 0.01 0.37 
75 BocVal 0.2 99.9 0.31 i 0.02 0.35 
74 BocAsp(OBzl) 0.7 99.8 0.31 i 0.02 0.33 
73 BocAla 0.0 100 0.29 i 0.01 0.33 
72 BocLys(2C1-Z) 1.1 99.6 0.30 i 0.02 0.30 
71 BocAsp(0Bzl) 1.3 99.5 0.28 r 0.02 0.28 
70 BocAla 0.0 100 0.23 :- 0.01 0.27 
‘Average values based on 2-4 ninhydrin analyses after coupling and deprotection in 
each cycle expressed as mmol/g of peptide-sheet. 
bNo residues were reooupled, but coupling of Boe-Sez-(Bzl) was followed by 
complete acetylation of remaining free amino groups using N-acetylimidazole in 
methylene chloride. 
‘These estimated values are calculated relative to the theoretical substitution after 
coupling of the Bee-protected residue. and do not include correction for incomplete 
coupling of the preceding residue. 
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(b) Cleavage, puri?cation and identi?cation of synthetic TABLE 7 
hPTH-(80-84) Molecular weights of hPTH compounds 
90 mg of H-Lys(ClZ)AlaLys(ClZ)Ser(Bzl)Gl 
nOCHg-Pam-sheet was treated with 5 ml of anhydrous 
HF/anisole (9:1 v/v) for 1 h at 0° C. to simultaneously 
deprotect the side-chain protecting groups and cleave 
the peptide from the sheet. Extractions with ether, to 
remove organic components such as anisole and alkyl 
ated anisoles, were followed by extraction into 10% 
aqueous acetic acid. Lyophilization gave 24.0 mg of 
crude product of high purity [see HPLC chromatogram 
in FIG. 2 (A)]. 
The crude product was puri?ed in two steps on a 
preparative C13 column (300x l9 mm). Buffers includ 
ing TFA were evaporated off under reduced pressure 
and the product was redissolved in water; the solution 
was ?ltered and lyophilized to give 17.8 mg of H 
LysAlaLys-SerGln-OH, as con?rmed by amino acid 
analysis (Table 6) and FABMS molecular weight mea 
surements (Table 7). 
The overall synthetic yield was approx. 84%, and the 
yield of pure peptide was approx. 69% based on the 
quantitative amino acid analysis. 
(0) Cleavage, puri?cation and identi?cation of synthetic 
hPTI-l-(75-84). 
93 mg of H-ValAsp(OBzl)ValLeuThr(Bzl)Lys(Cl 
Z)AlaLys(ClZ)Ser(Bzl)Gln-OCHZ-Pam-Sheet was 
treated in the same manner as for hP’I‘H-(80-84), giving 
36.6 mg of crude product [see HPLC chromatogram in 
FIG. 2 (B)], and ?nally 27.2 mg of puri?ed peptide, 
identi?ed by amino acid analysis (Table 6) and molecu 
lar weight measurements (Table 7). The overall syn 
thetic yield was approx. 85%, and the yield of pure 
peptide was approx. 69%, based on the quantitative 
amino acid analysis. 
(d) Cleavage, puri?cation and identi?cation of synthetic 
hPTH-(70-84) 
The hPTH-(70-84) fragment was released from 96 
mg of peptide-sheet in the same way as in (b) and (c), 
above [see HPLC chromatogram in FIG. 2 (C)]. The 
overall synthetic yield was approx. 83% and the yield 
of pure peptide was 26 mg (approx. 63%). The pure 
peptide was identi?ed by amino acid analysis (Table 6) 
and molecular weight measurements (Table 7). 
TABLE 6 
Amino acid composition of puri?ed synthetic hP'l'l-l compounds 
Molar ratio“ 
Amino acid hP'l'H-(70-84) hPl'H-(7S-84) hP'I'H-(SO-84) 
Asp 2.94 (3) 1.01 (1) - 
Thrb 0.99 (1) 0.95 (1) - 
Serb 1.05 (1) 0.81 (1) 0.194(1) 
610 1.31 (1) 1.03 (1) 1.07 (1) 
Ala 3.00 (3) 1.00 (1) 1.00 (1) 
Val 2.00 (2) 2.00 (2) — 
Leu 1.03 (1) 1.00 (1) - 
Lys 3.08 (s) 1.91; (2) 1.89 (2) 
Hydrolyses were performed in sealed, evacuated 
tubes with 5.7M HCl containing 0.05% phenol, 110° C., 
20 h. Analysis by HPLC using fluorescence detection 
(338/450 nm) following treatment (post-column) with 
an o-phthaldialdehyde derivatizing reagent. 
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Molecular wei ht 
Peptide measured calculated 
hP'TH-(80-84) 560.3 560.3 
hPTH-(75-84) 1088 1088 
hPTH-(70-84) 1588 1588 
Determined by quadrupole mass spectrometry. The 
calculated m/z values are for (3: 12.000 u and H: 1.008 
u. 
EXAMPLE 9 
Rapid parallel synthesis of multiple peptide analogs 
(a) Labeling of sheets 
Aminomethylated 285 wt % polystyrene-grafted 
polyethylene sheet (0.6 mmol NHZ/g sheet) was cut 
into thirteen discrete pieces (each piece: 1.5 X 3 cm, ca. 
50 pm thickness, ca. 40 mg) and labeled individually by 
means of graphite-based ink. A piece of polyethylene 
?lm was placed on top of each labeled surface and 
melted into the grafted sheet by using an electrically 
heated sealing apparatus. Finally, the sheets were 
shaken in 50% TFA/CHgClz for 20 min. to check that 
all labels were adequately sealed in. 
(b) Simultaneous synthesis ofmelittin-(7-21) and twelve 
analogs on labeled sheets 
Protected melittin-(7-2l), i.e. 
7 12 14 
Boc-Lys(C lZ)~Val-Leu-Thr(Bz l)-Thr(B z l)-Gl y-Le u-ProaAla 
Len-Ile 
2 1 
and twelve analogs derived by substitutions in positions 
12 and 14 (sequences of the free peptides are listed in 
FIG. 3) were each assembled stepwise on a labeled 
sheet. The common steps of deprotection, neutraliza 
tion, washing and coupling of identical amino acids 
were performed simultaneously in a single reaction 
vessel, while the coupling of different amino acids was 
carried out in separate vessels. 
A standard solid-phase procedure was employed, 
using double DCC coupling (3.5 equiv., 0.05M, in 30% 
DMF/CHgClg) of all residues except for Boc-Gln and 
Boc-Asn, which were double coupled as HOBt esters in 
30% DMF/Cl-lzClg, and Boe-Leul3 to Gin“, which 
was double coupled as a symmetric anhydride in 20% 
DMF/CHZCIZ. 
Following removal of the N-terminal Boc group, 
deprotection and release of the peptides from the sheets 
were accomplished by the low/high HF method (T am 
et al., J. Am. Chem. Soc., 105, 6442 (1983)). The free 
l5-residue peptides were obtained in overall synthetic 
yields of ca. 70%. FIG. 4 shows HPLC chromatograms 
of the thirteen unpuri?ed peptides. All peptides were 
puri?ed in l-2 steps on a semi-preparative C13 column. 
As an example, 3.2 mg of pure me1ittin-(7-21) was ob 
tained from 1 cm2 (23.2 mg) of fully protected peptide 
sheet. The identity of the peptides was veri?ed by 
amino acid analysis (Table 8) and molecular weight 
measurements (Table 9). 
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TABLE 8 
Amino acid composition of puri?ed melittin-(7-2l) and its analogs 
Molar ratio“ 
Amino acid pept. 1 pept. 2 pept. 3 pept. 4 pept. 5 pept. 6 pept. 7 pept. 8 pept. 9 pept. 10d pept. ll pept. l2 pept. l3 
Lys 1.95 (2) 1.69 (2) 1.77 (2) 2.83 (3) 1.47 (2) 1.87 (2) 1.71 (2) 1.83 (2) 1.93 (3) (2) 1.75 (2) 1.66 (2) 2.62 (3) 
Val 0.65 (1) 0.82 (1) 0.87111) 0.78 (l) 0.87 (1) 0.88 (1) 0.81 (1) 0.88 (I) 0.87 (1) (1) 1.75 (2) 0.81 (l) 0.89 (1) 
Leu 2.97 (3) 2.85 (3) 2.94 (3) 2.67 (3) 2.86 (3) 2.92 (3) 2.93 (3) 3.90 (4) 3.06 (3) (3) 2.73 (3) 3.70 (4) 3.71 (4) 
Thrb 1.87 (2) 1.89 (2) 1.93 (2) 1.70 (2) 1.84 (2) 1.87 (2) 1.90 (2) 1.88 (2) 2.06 (2) (2) 1.92 (2) 1.62 (2) 1.93 (2) 
Gly 1.08 (1) 103(1) 2.04 (2) 1.07 (l) 1.12 (l) 1.09 (1) 108(1) 1.05 (1) 126(1) (1) 1.05(l) — — 
Pro 0.98 (l) 0.98 (l) -— — — 
Ala 1.00 (1) 1.00 (1) 1.00 (1) 1.00(1) 1.00(1) 1.00 (1) 1.00(1) 1.00 (1) 1.00(1) (l) 1.00(1) 1.00(1) 1.00(1) 
Ile 1.93 (2) 1.75 (2) 1.81 (2) 1.75 (2) 1.77 (2) 1.82 (2) 1.80 (2) 1.83 (2) 1.95 (2) (2) 1.73 (2) 1.73 (2) 1.130(2) 
Serb 0.90 (1) 0.96 (1) 0.97 (1) 1.00 (1) 0.98 (1) 0.95 (1) 1.88 (2) 095(1) 1.0](1) (1) 0.97 (1) 1.00(1) 0.95 (1) 
Trp‘ 
Asp _ _ ._ _ (1) 1.04 (1) - — - 
Phe —— — -- 0.91 (1) (1) 
611.1 - 1.12 (1) - 
"Values in parenthess are theoretical. 
bl'hr and Ser values were not corrected for loss during hydrolysis. 
‘Trypwphan was not determined. 
dl-"eptit‘le analog number 10 was not analyzed. 
The peptides were hydrolyzed in 5.7M HCl at 110° C. 
for 18 h in sealed non-evacuated tubes, except peptide 1 
which was hydrolyzed for 24 h in an evacuated tube. 
After ?ltration, hydrolysates were analyzed on a Beck 
anchoring linkage via which said at least N-protected 
amino acid is coupled. 
3. A polystyrene-grafted polymer substrate as 
claimed in claim 1 or 2, the estimated peak molecular 
man 6300 amino acid analyzer. 25 weight of the polystyrene chains grafted to the poly 
mer, not including substituents, being in the range of 
, TABLET? 300,000—l,600,000. , 
Mdwmzhts Ofmel1tt1n-(7-21)ana1o5§°_ 4. A polystyrene-grafted polymer substrate as 
‘ Mdecul“ ‘"1511’ b claimed in claim 1 or 2, which has been prepared from 
Pepude measured calculated A 30 a polymer substrate in the form of a sheet or ?lm of 
1 1640.5 1640.0 +0.5 thickness in the range of 25 to 100 pm, and in which the 
i {233-3 :3‘: degree of polystyrene chain grafting of the polymer 
4 167122 1671:‘ Hi‘ substrate is in the range of 5-800% by weight. 
5 1658.0 1658.0 0.0 5. A polystyrene-grafted polymer substrate as 
6 1657.0 1657-0 00 35 claimed in claim 1 or 2, which has been prepared from 
7 1630-2 163°” +01 a polymer substrate in the form of a sheet or ?lm of 
8 1656.1 1656.0 +0.1 1h. kn . th m5 100 d . hi h h 9 16900 ‘69m _()_1 1c ess 1n e range 0 to 11m, an 1n w c t e 
10 1690.3 1690.1 +0.2 degree of polystyrene Chain grafting of the polymer 
1; 1642.2 +3? substrate is in the range of 700—600% by weight. 
1727.4 . + . _ 13 mm 17272 +01 40 6. A polystyrene grafted polymer substrate as 
“Determined by 2S2Cf fission fragment time of ?ight mass spectrometry from the 
mean 01‘ the most abundant isotopes. 
M = meuured - calculated. 
We claim: 
1. A polymer substrate grafted with polystyrene 
chains and to which a peptide or protein is coupled, said 
polystyrene chains being selected from the group con 
sisting of unsubstituted polystyrene chains and polysty 
rene chains bearing substituents which are not reactive 
under the conditions prevailing in peptide synthesis, the 
estimated peak molecular weight of the polystyrene 
chains grafted to the polymer, not including substitu 
ents, being at least 200,000, the polystyrene moiety of 
the polystyrene-grafted polymer substrate bearing an 
anchoring linkage via which said peptide or protein is 
coupled. 
2. A polymer substrate grafted with polystyrene 
chains and to which an at least N-protected and, when 
applicable, side-chain protected amino acid is coupled, 
said polystyrene chains being selected from the group 
consisting of unsubstituted polystyrene chains and poly 
styrene chains bearing substituents which are not reac 
tive under the conditions prevailing in peptide synthe 
sis, the estimated peak molecular weight of the polysty 
rene chains grafted to the polymer, not including sub 
stituents, being at least 200,000, the polystyrene moiety 
of the polystyrene-grafted polymer substrate bearing an 
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claimed in claim 1 or 2, which is in the form of a sheet 
or ?lm. 
7. A polystyrene-grafted polymer substrate as 
claimed in claim 6, which has a thickness of from 10 to 
10,000 p.111. 
8. A polystyrene-grafted polymer substrate as 
claimed in claim 1 or 2, wherein the polymer is a poly 
ole?n. 
9. A polystyrene-grafted polymer substrate as 
claimed in claim 1 or 2, wherein the polymer is polyeth 
ylene. 
10. A method for spectrophotometric monitoring of 
an antibody/antigen reaction, wherein a peptide-bear 
ing polystyrene-grafted polyethylene substrate as 
claimed in claim 1 is used as a light-transparent carrier 
material, and wherein said antigen is said peptide cou 
pled to the polystyrene-grafted polyethylene substrate. 
11. A polystyrene-grafted polymer substrate as 
claimed in claim 1 or 2, in the form of a bead, pellet, 
disc, ring, tube, rod or net. 
12. A polymer substrate grafted with polystyrene 
chains, said polystyrene chains being selected from the 
group consisting of unsubstituted polystyrene chains 
and polystyrene chains bearing substituents which are 
not reactive under the conditions prevailing in peptide 
synthesis, the estimated peak molecular weight of the 
polystyrene chains grafted to the polymer, not includ 
ing substituents, being at least 200,000, the polystyrene 
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moiety of the polystyrene-grafted polymer substrate 
being functionalized with a chemical functionality facil 
itating the formation of an anchoring linkage between 
the polystyrene moiety and an at least N-protected 
amino acid selected from the group consisting of i) 5 
N-protected and, when applicable, side-chain protected 
amino acids and ii) N-protected and carboxy] terminal 
derivatized and, when applicable, side-chain protected 
amino acids. 
13. A polystyrene-grafted polymer substrate as 
claimed in claim 12, wherein the estimated peak molec 
ular weight of the polystyrene chains grafted to the 
polymer, not including substituents, is in the range of 
300,000-l,600,000. 
14. A polystyrene-grafted polymer substrate as 
claimed in claim 12, which has been prepared from a 
polymer substrate in the form of a sheet or ?lm of thick 
ness in the range of 25 to 100 um, and in which the 
degree of polystyrene chain grafting of the polymer 
substrate is in the range of 5—800% by weight. 
15. A polystyrene-grafted polymer substrate as 
claimed in claim 12, which has been prepared from a 
polymer substrate in the form of a sheet or ?lm of thick 
ness in the range of 25 to 100 um, and in which the 
degree of polystyrene chain grafting of the polymer 
substrate is in the range of IOU-600% by weight. 
16. A polystyrene-grafted polymer substrate as 
claimed in claim 12, which is in the form of a sheet or 
?lm. 
17. A polystyrene-grafted polymer substrate as 
claimed in claim 16, which has a thickness of from 10 to 
10,000 um. 
18. A polystyrene-grafted polymer substrate as 
claimed in claim 12, wherein the chemical functionality 
facilitating the formation of an anchoring linkage be 
tween an at least N-protected amino acid and the func 
tionalized polystyrene moiety is selected from the 
group consisting of: 
chloro-, bromo- and iodo-substituted alkyl and deriv 
atives thereof; 
amino- and aryl-substituted alkyl and derivatives 
thereof; 
amino- and alkylaryl-substituted alkyl and derivatives 
thereof; 
hydroxy-substituted alkyl and derivatives thereof; 
and 
amino-substituted alkyl and derivatives thereof, 
said derivatives being functionalities with a spacer 
group such that a synthesized peptide or protein 
chain will be cleavable from the polystyrene moi 
ety substantially without degradation of said chain. 
19. A polystyrene-grafted polymer substrate as 
claimed in claim 12, wherein the chemical functionality 
facilitating the formation of an anchoring linkage be 
tween an at least N-protected amino acid and the func 
tionalized polystyrene moiety is selected from the 
group consisting of: 
chloromethyl and derivatives thereof; 
a-aminobenzyl and derivatives thereof; 
a-amino-2-, a-amino-3- and a-amino-4-methylbenzyl 
and derivatives thereof; 
hydroxymethyl and derivatives thereof; and 
aminomethyl and derivatives thereof, 
said derivatives being functionalities with a spacer 
group such that a synthesized peptide or protein 
chain will be cleavable from the polystyrene moi 
ety substantially without degradation of said chain. 
15 
25 
30 
45 
50 
55 
65 
26 
20. A polystyrene-grafted polymer substrate as 
claimed in claim 12, wherein the functionality is derived 
from an amino group-containing moiety selected from 
the group consisting of: 
amino-substituted alkyl; 
amino- and aryl-substituted alkyl; and 
amino- and alkylaryl-substituted alkyl, 
and the functionality comprises a spacer group de 
rived from a member of the group consisting of: 
4-(haloalkyl)aryl-lower alkanoic acids; 
Boc-aminoacyl-4-(oxymethyl)aryl-lower 
acids; 
N-Boc-p-acylbenzhydrylamines 
N-Boc-4'-lower alkyl-p-acylbenzhydrylamines; 
N-Boc-4’-lower alkoxy-p-acylbenzhydrylamines; and 
4-hydroxymethylphenoxy-lower alkanoic acids. 
21. A polystyrene-grafted polymer substrate as 
claimed in claim 12, wherein the polymer is a polyole 
?n. 
22. A polystyrene-grafted polymer substrate as 
claimed in claim 13, wherein the polymer is polyethyl 
ene. 
23. A method for the preparation of a functionalized 
polystyrene-grafted polymer substrate as claimed in 
claim 218, the method comprising the steps of: 
subjecting a polymer substrate immersed in a solution 
of a styrene monomer in an organic solvent to a 
treatment leading to the formation of free radicals 
such that polystyrene chains are grafted to the 
polymer substrate, said styrene monomer being 
selected from the group consisting of a) unsubsti 
tuted styrene monomer and b) substituted styrene 
monomers which bear substituents such that the 
substituents in the substituted polystyrene chains 
grafted to the polymer substrate are not reactive 
under the conditions prevailing in peptide synthe 
sis, and 
functionalizing the polystyrene moiety of the polysty 
rene-grafted polymer substrate with a chemical 
functionality facilitating the formation of an an 
choring linkage between the polystyrene moiety 
and an at least N-protected amino acid selected 
from the group consisting of i) N-protected and, 
when applicable, side-chain protected amino acids 
and ii) N-protected and carboxyl terminal deriva 
tized and, when applicable, side-chain protected 
amino acids. 
24. A polystrene-grafted polymer substrate as 
claimed in claimed 12, in the form of a bead, pellet, disc, 
ring, tube, rod or net. 
25. A method for the preparation of a polymer sub 
strate grafted with polystyrene chains and to which is 
coupled an at least N-protected and, when applicable, 
side-chain protected amino acid, said polystyrene 
chains being selected from the group consisting of un 
substituted polystyrene chains and polystyrene chains 
bearing substituents which are not reative under the 
conditions prevailing in peptide synthesis, the estimated 
peak molecular weight of the polystyrene chains 
grafted to the polymer, not including substituents, being 
at least 200,000, the polystyrene chains of the polysty 
rene-grafted polymer substrate bearing an anchoring 
linkage via which said at least N-protected amino acid is 
coupled, the method comprising the steps of: 
subjecting a polymer substrate immersed in a solution 
of a styrene monomer in an organic solvent to a 
treatment leading to the formation of free radicals 
such that polystyrene chains are grafted to the 
alkanoic 
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polymer substrate, said styrene monomer being 
selected from the group consisting of a) unsubsti 
tuted styrene monomer and b) substituted styrene 
monomers which bear substituents such that the 
substituents in the substituted polystyrene chains 
grafted to the polymer substrate are not reactive 
under the conditions prevailing in peptide synthe 
sis, 
functionalizing the polystyrene moiety of the polysty 
rene, grafted polymer substrate with a chemical 
functionality facilitating the formation of an an 
choring linkage between the polystyrene moiety 
and an at least N-protected amino acid selected 
from the group consisting of i) N-protected and, 
when applicable, side-chain protected amino acids 
and ii) N-protected and carboxyl terminal deriva 
tized and, when applicable, side-chain protected 
amino acids, and 
reacting said functionality with a said at least N 
protected amino acid so as to form an anchoring 
linkage to the at least N-protected amino acid. 
26. A method as claimed in claim 23 or 25, wherein 
the polymer substrate is in the form of a bead, pellet, 
disc, ring, tube, rod or net. 
27. A method as claimed in claim 23 or 25, wherein 
the treatment leading to the formation of free radicals is 
gamma irradiation. 
28. A method as claimed in claim 23 or 25, wherein 
the treatment leading to the formation of free radicals is 
gamma irradiation, the gamma irradiation being per 
formed using a gamma radiation dose rate of from about 
1 to about 100,000 Gy/hour. 
29. A method as claimed in claim 23 or 25, wherein 
the treatment leading to the formation of free radicals is 
gamma irradiation, the gamma irradiation being per 
formed using a gamma radiation dose rate of from about 
300 to about 1,000 Gy/hour. 
30. A method as claimed in claim 23 or 25, wherein 
the organic solvent is an alcohol. 
31. A method as claimed in claim 23 or 25, wherein 
the organic solvent is a C14 aliphatic alcohol. 
32. A method as claimed in claim 23 or 25, wherein 
the organic solvent is methanol. 
33. A method as claimed in claim 23 or 25, wherein 
the volume percentage (% v/v) of said styrene mono 
mer in the solution is such that l<% v/v <95. 
34. A method as claimed in claim 23 or 25, wherein 
the volume percent (% v/v) of said styrene monomer in 
the solution is such that 25§% v/véSS. 
35. A method as claimed in claim 23 or 25, wherein 
the grafting is performed so as to give an estimated peak 
molecular weight of the polystyrene chains grafted to 
the polymer, not including substituents, in the range of 
300,000-l,600,000. 
36. A method as claimed in claim 23 or 25, wherein 
the polymer substrate is in the form of a sheet or ?lm of 
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thickness in the range of 25 to 100 um, and the grafting 
is performed so as to give a degree of polystyrene chain 
grafting of the polymer substrate in the range of 
5—800% by weight. 
37. A method as claimed in claim 23 or 25, wherein 
the polymer substrate is in the form of a sheet or ?lm of 
thickness in the range of 25 to 100 um, and the grafting 
is performed so as to give a degree of polystyrene chain 
grafting of the polymer substrate in the range of 
100-600% by weight. 
38. A method as claimed in claim 23 or 25, wherein 
the polymer substrate is in the form of a sheet or ?lm. 
39. A method as claimed in claim 38, wherein the 
polymer substrate has a thickness of from 10 to 10,000 
um. 
40. A method as claimed in claim 38, wherein the 
polymer substrate has a thickness of from 25 to 100 um. 
41. A method as claimed in claim 23 or 25, wherein 
the chemical functionality facilitating the formation of 
an anchoring linkage between an at least N-protected 
amino acid and the functionalized polystyrene moiety is 
selected from the group consisting of: 
chloro-, bromo- and iodo-substituted alkyl and deriv 
atives thereof; 
arnino- and aryl-substituted alkyl and derivatives 
thereof; 
amino- and alkylaryl-substituted alkyl and derivatives 
thereof; 
hydroxy-substituted alkyl and derivatives thereof; 
and 
amino-substituted alkyl and derivatives thereof, 
said derivatives being functionalities with a spacer 
group such that a synthesized peptide or protein 
chain will be cleavable from the polystyrene moi 
ety substantially without degradation of said chain. 
42. A method as claimed in claim 23 or 25, wherein 
the chemical functionality facilitating the formation of 
an anchoring linkage between an at least N-protected 
amino acid and the functionalized polystyrene moiety is 
selected from the group consisting of: 
chloromethyl and derivatives thereof; 
a-aminobenzyl and derivatives thereof; 
a-amino-2-, a-amino-3- and a-amino-‘l-methylbenzyl 
and derivatives thereof; 
hydroxymethyl and derivatives thereof; and 
aminomethyl and derivatives thereof, 
said derivatives being functionalities with a spacer 
group such that a synthesized peptide or protein 
chain will be cleavable from the polystyrene moi 
ety substantially without degradation of said chain. 
43. A method as claimed in claim 23 or 25, wherein 
the polymer is a polyole?n. 
44. A method as claimed in claim 23 or 25, wherein 
the polymer is polyethylene. 
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